Overview

Effects of N-acetylcysteine on Low T3 Syndrome

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The propose of this study is to determine whether N-acetylcysteine is effective in reversing the changes in thyroid hormones seen in critical illness, known as the low T3 syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Federal University of Rio Grande do Sul
Collaborators:
Hospital de Clinicas de Porto Alegre
Programa de pós-graduação em endocrinologia
Treatments:
Acetylcysteine
N-monoacetylcystine